Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 6/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 1.00 |
| ▸ | TTR | P02766 | 5/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | MEN1 | O00255 | 4/20 | 1.00 |
| ▸ | MAPT | P10636 | 4/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 4/20 | 1.00 |
| ▸ | CYP1A1 | P04798 | 4/20 | 1.00 |
| ▸ | PTGS2 | P35354 | 4/20 | 1.00 |
| ▸ | CYP1B1 | Q16678 | 4/20 | 1.00 |
| ▸ | ALOX5 | P09917 | 4/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | TP53 | P04637 | 3/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 3/20 | 1.00 |
| ▸ | HPGD | P15428 | 3/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 3/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cis-Resveratrol SCHEMBL1931746 | 1.00 | PTGS1 (1.00) | PTGS1KDM4ETTRLMNAMEN1 | |
| Resveratrol SCHEMBL17629801 | 1.00 | PTGS1 (1.00) | PTGS1KDM4ETTRLMNAMEN1 | |
| Resveratrol SCHEMBL15106855 | 1.00 | PTGS1 (1.00) | PTGS1KDM4ETTRLMNAMEN1 | |
| Resveratrol SCHEMBL19425 | 1.00 | PTGS1 (1.00) | PTGS1KDM4ETTRLMNAMEN1 | |
| Resveratrol SCHEMBL19426 | 1.00 | PTGS1 (1.00) | PTGS1KDM4ETTRLMNAMEN1 | |
| Resveratrol SCHEMBL3704258 | 1.00 | PTGS1 (1.00) | PTGS1KDM4ETTRLMNAMEN1 | |
| Resveratrol SCHEMBL20164915 | 1.00 | PTGS1 (1.00) | PTGS1KDM4ETTRLMNAMEN1 | |
| Resveratrol SCHEMBL31096991 | 0.97 | PTGS1 (0.95) | PTGS1KDM4ETTRLMNAMEN1 | |
| Resveratrol SCHEMBL3405900 | 0.97 | PTGS1 (0.95) | PTGS1KDM4ETTRLMNAMEN1 | |
| Resveratrol SCHEMBL22469907 | 0.97 | PTGS1 (0.95) | PTGS1KDM4ETTRLMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3760184-B1 | COMPOSITION COMPRISING STABILIZED PHYCOCYANIN AND ITS USES | CALICEA (FR) | 2023-02-15 | — | — | EP | claimed |
| CN-110960532-A | Composition of anti-coronavirus macleaya cordata benzylisoquinoline alkaloid and resveratrol and application thereof | 金晓飞 | 2020-04-07 | — | — | CN | claimed |
| CN-105007718-B | Unhulled rice with resveratrol biosynthesis and application thereof | 大韩民国（农村振兴厅长） | 2018-07-20 | — | — | CN | claimed |
| EP-2352836-B1 | Method of preparing piceatannol using bacterial cytochrome p450 and composition therefor | YUN CHUL HO (KR) | 2016-03-30 | — | — | EP | claimed |
| US-9192673-B2 | Fine dry particulate resveratrol active agent compositions and topical formulations including the same | LABORATORY SKIN CARE, INC. (US) | 2015-11-24 | — | — | US | claimed |
| US-6824790-B2 | CAPSULE, TABLET WITH ENTERIC, PROTECTIVE COATINGS; BIOAVAILABILITY | ENZREL INC. | 2004-11-30 | — | — | US | claimed |
| EP-1117394-B1 | USE OF CARNITINES AND RESVERATROL TO PRODUCE A COMPOSITION FOR THE PREVENTION OR THERAPEUTIC TREATMENT OF CEREBRAL DISORDERS BROUGHT ABOUT BY AGEING AND USE OF NEUROTOXIC DRUGS | SIGMA TAU HEALTHSCIENCE SPA (IT) | 2003-09-17 | — | — | EP | claimed |
| EP-1221949-A2 | METHOD AND COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF SYMPTOMS ASSOCIATED WITH COLD AND INFLUENZA-LIKE ILLNESSES | THE PROCTER & GAMBLE COMPANY (US) | 2002-07-17 | — | — | EP | claimed |
| WO-2001008671-A2 | METHOD AND COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF SYMPTOMS ASSOCIATED WITH COLD AND INFLUENZA-LIKE ILLNESSES | THE PROCTER & GAMBLE COMPANY (US) | 2001-02-08 | — | — | WO | claimed |
| US-20210378193-A1 | HAPLOID EMBRYOGENESIS | STICHTING WAGENINGEN RESEARCH (NL) | 2021-12-09 | — | — | US | disclosed |
| CN-113384640-A | Grape leaf extract and preparation method thereof | 劲牌持正堂药业有限公司 | 2021-09-14 | — | — | CN | disclosed |
| US-20210244703-A1 | USE OF SCIENTIFICALLY MATCHED PLANT SUPPLEMENTS COMBINED WITH ANTINEOPLASTIC COMPOUNDS FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES | Brio Ventures, LLC (US) | 2021-08-12 | — | — | US | disclosed |
| US-10966381-B2 | Haploid embryogenesis | STICHTING WAGENINGEN RESEARCH (NL) | 2021-04-06 | — | — | US | disclosed |
| CN-110386881-B | Diarylethene compound, pharmaceutical composition and application thereof | 中国科学院昆明植物研究所 | 2021-03-02 | — | — | CN | disclosed |
| CN-1628687-A | Medicine composition for treating prostatitis | YANG SHIJIE (CN) | 2005-06-22 | — | — | CN | disclosed |
| CN-1628774-A | Vitis botanical extractive, its preparation method and its novel usage as an antibacterials synergist | WANG XIUYING (CN) | 2005-06-22 | — | — | CN | disclosed |
| EP-1503776-A1 | METHOD OF ENHANCING BIOLOGICAL ACTIVITY OF PLANT EXTRACTS | E-L Management Corp. (US) | 2005-02-09 | — | — | EP | disclosed |
| WO-2003092711-A1 | METHOD OF ENHANCING BIOLOGICAL ACTIVITY OF PLANT EXTRACTS | E-L MANAGEMENT CORP. (US) | 2003-11-13 | — | — | WO | disclosed |
| EP-1221949-A2 | METHOD AND COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF SYMPTOMS ASSOCIATED WITH COLD AND INFLUENZA-LIKE ILLNESSES | THE PROCTER & GAMBLE COMPANY (US) | 2002-07-17 | — | — | EP | disclosed |
| WO-2001008671-A2 | METHOD AND COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF SYMPTOMS ASSOCIATED WITH COLD AND INFLUENZA-LIKE ILLNESSES | THE PROCTER & GAMBLE COMPANY (US) | 2001-02-08 | — | — | WO | disclosed |